Supriya Lifescience IPO GMP, Price, Date, Allotment

Supriya Lifescience IPO description – The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with focus on research and development. As of 31 October 2021, it had niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. The company has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-50% and 60-65%, respectively, of the API exports from India, between Fiscal 2017 and 2021. It was among the largest exporters of Salbutamol Sulphate in India contributing to 31% of the API exports from India in FY 2021 in volume terms.

Its pharmaceutical business is organized into domestic and export sales. From 1 April 2020 until 31 October 2021, its products were exported to 86 countries to 1,296 customers including 346 distributors.  Its customers include global pharma companies such as Syntec Do Brasil LTDA, American International Chemical Inc and AT Planejamento E Desenbolvimento De Negocios Ltda, with whom we have business relationship for over nine years, and Suan Farma Inc, Acme Generics LLP, Akum Drugs Ltd and Mankind Pharma Ltd with whom it has business relationship for over four years.

Supriya Lifescience’s business operations are supported by a manufacturing facility located in Parshuram Lote, Maharashtra, which is approximately 250 km from Mumbai, Maharashtra. The manufacturing facility is spread across 23,806 sq. mts, having reactor capacity of 547 KL/ day and seven cleanrooms. In addition, the company has acquired a plot of land, admeasuring 12,551 sq.mt, near the present manufacturing facility, wherein it intends to expand its manufacturing infrastructure.

Promoters of Supriya Lifescience Limited – Satish Waman Wagh

---

Supriya Lifescience IPO Details

Subscription Dates	16 – 20 December 2021
Price Band	INR265 – 274 per share
Fresh issue	INR200 crore
Offer For Sale	INR500 crore
Total IPO size	INR700 crore
Minimum bid (lot size)	54 shares
Face Value	INR 2 per share
Retail Allocation	10%
Listing On	NSE, BSE

---

Supriya Lifescience’s Financial Performance

	FY2019	FY2020	FY2021	H1 FY2022
Revenue	285.9	322.7	396.2	230.1
Expenses	213.1	213.3	218.1	131.4
Net income	39.4	73.4	123.8	66.0
Margin (%)	13.8	22.7	31.2	28.7

---

Supriya Lifescience IPO News

• Supriya Lifescience IPO Allotment: Check Status in 4 Easy Ways
• Supriya Lifescience IPO Review: Better then listed peers
• Supriya Lifescience RHP
• Supriya Lifescience DRHP

---

Supriya Lifescience Valuations & Margins

	FY2019	FY2020	FY2021
EPS	5.39	10.03	16.92
PE ratio	–	–	15.66 – 16.19
RONW (%)	42.03	49.20	46.04
ROCE (%)
EBITDA (%)	25.45	33.92	44.96
Debt/Equity	0.94	0.55	0.26
NAV	–	–	36.75

---

Supriya Lifescience IPO GMP Daily Trend

Date	Supriya Lifescience IPO GMP	Kostak	Subject to Sauda
27 Dec 2021	INR150	INR200	INR4,000
25 Dec 2021	INR130	INR200	INR4,000
24 Dec 2021	INR150	INR200	INR4,000
23 Dec 2021	INR120	INR200	INR3,500
22 Dec 2021	INR100	INR150	INR3,000
21 Dec 2021	INR130	INR150	INR3,500
20 Dec 2021	INR150	INR150	INR3,500
18 Dec 2021	INR250	INR200	INR4,000
17 Dec 2021	INR220	INR200	INR3,800
16 Dec 2021	INR250	INR250	INR3,800
15 Dec 2021	INR250	INR300	INR4,000
14 Dec 2021	INR250	–	–

---

Supriya Lifescience IPO Subscription – Live Updates

Category	Shares Offered	Day 1	Day 2	Day 3
QIB	79,24,527	0.00	0.53	31.83
NII	39,62,263	0.66	2.90	161.22
Retail	26,41,509	11.84	25.38	55.75
Total	1,45,28,299	2.33	5.69	71.47

---

Supriya Lifescience IPO Reviews – Subscribe or Avoid?

Angel One – Subscribe
Anand Rathi – Subscribe for long term
Antique Stock Broking –
Arihant Capital –
Ashika Research – Subscribe
Asit C Mehta –
BP Wealth – Subscribe
Canara Bank Securities – Subscribe
Choice Broking – Subscribe
Elite Wealth – Subscribe
GEPL Capital –
Hem Securities – Subscribe
ICICIdirect – Unrated
KR Choksey –
Marwadi Financial Services – Subscribe
Motilal Oswal – Subscribe
Nirmal Bang – Subscribe
Religare Broking –
Samco Securities – Subscribe
SMC Global – 2.5/5
Ventura Securities – Subscribe

---

Supriya Lifescience Offer Registrar

Link Intime India Private Limited 
C-101, 1st Floor,
247 Park Lal Bahadur Shastri Marg,
Vikhroli (West) Mumbai – 400 083
Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: [email protected]
Website: http://www.linkintime.co.in

---

Supriya Lifescience Contact Details

Supriya Lifescience Limited
207/208, Udyog Bhavan,
Sonawala Road, Goregaon – East,
Mumbai – 400063, Maharashtra
Phone: +91 22-40332727
Email: [email protected]
Website: www.supriyalifescience.com

---

Supriya Lifescience IPO Allotment Status

Supriya Lifescience IPO allotment is now available on Link Intime’s website. Click on this link to get allotment status.

---

Supriya Lifescience IPO Timetable

IPO Opening Date	16 December 2021
IPO Closing Date	20 December 2021
Finalisation of Basis of Allotment	23 December 2021
Initiation of refunds	24 December 2021
Transfer of shares to demat accounts	27 December 2021
Listing Date	28 December 2021
Opening Price on NSE	INR421 per share (up 53.65% from IPO price)
Closing Price on NSE	INR389.7 per share (up 42.23% from IPO price)

---

Supriya Lifescience IPO FAQs